For those talking about RS, share structure concerns, spewing BS:
JP’s email to me on July 13:
Dear Karl,
Thanks for your email and thanks for your support which we greatly appreciate.
I understand the hesitation/concern across the OTC community however as an ILUS Shareholder, this concern would not be relevant to the acquisition of Quality International by Wikisoft Corp., which is majority owned by ILUS.
ILUS is using Wikisoft Corp. as the special purpose vehicle to acquire Quality International. Therefore, there would be no conversion of “billions” of ILUS shares.
This strategy protects the ILUS SS - we have always stated that our goal is to build a sustainable business and create long term shareholder value – this is the outworking of us achieving that goal.
We have stated on several occasions that a RS is not on the table for discussion.
If the market is concerned about ILUS converting billions of shares (or any shares) for large acquisitions, it’s because the market has not read or digested the press releases and all the videos and updates we provide. If the market is concerned about a reverse split, again, it’s because they have not listened to or digested our repeated communication in this regard. Many people only want to look for negatives and spread rumours and, in many cases, those who are new to ILUS or those who haven’t done their due diligence will fall for it. A company such as ILUS which comes along and does the big things differently isn’t always easily understood by a market which has every reason to question everything and operate from a position of concern because of the way most OTC management teams have operated and continue to operate. We are doing things differently and our results will prove that.
I trust the above clarifies for you. If you have any more questions, please let me know.
Best regards,
John-Paul Backwell
Director
News 
Market Data 
Discover 
AI
